Previous studies have reported that inhibiting Drp1 function attenuates mitochondrial dysfunction and neurotoxicity in Parkinson’s Disease (PD) cell culture, providing preliminary evidence for future studies assessing the effect of blocking Drp1 in ALS [114]. Here, DNM1L is linked to amyotrophic lateral sclerosis.